Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males: A Meta-analytic Approach Using National Registries
The DOI matches its Crossref record, with a small difference in title or year; 39 of the 45 references it cites were found in a registry or an index.
Abstract
Background The large observed variability in hemophilia prevalence prevents robust estimation of burden of disease. Objective To estimate the prevalence and prevalence at birth of hemophilia and the associated life expectancy disadvantage. Design Random-effects meta-analysis of registry data. Setting Australia, Canada, France, Italy, New Zealand, and the United Kingdom. Participants Male patients with hemophilia A or B. Measurements Prevalence of hemophilia as a proportion of cases to the male population, prevalence of hemophilia at birth as a proportion of cases to live male births by year of birth, life expectancy disadvantage as a 1 - ratio of prevalence to prevalence at birth, and expected number of patients worldwide based on prevalence in high-income countries and prevalence at birth. Results Prevalence (per 100 000 males) is 17.1 cases for all severities of hemophilia A, 6.0 cases for severe hemophilia A, 3.8 cases for all severities of hemophilia B, and 1.1 cases for severe hemophilia B. Prevalence at birth (per 100 000 males) is 24.6 cases for all severities of hemophilia A, 9.5 cases for severe hemophilia A, 5.0 cases for all severities of hemophilia B, and 1.5 cases for severe hemophilia B. The life expectancy disadvantage for high-income countries is 30% for hemophilia A, 37% for severe hemophilia A, 24% for hemophilia B, and 27% for severe hemophilia B. The expected number of patients with hemophilia worldwide is 1 125 000, of whom 418 000 should have severe hemo…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HA and hemophilia B (HB) are X-linked monogenic disorders resulting from decreased/absent function of coagulation FVIII or FIX.165,166”
From Current clinical applications of in vivo gene therapy with AAVs (2021) · cites this paper as [165]
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Random-effects model for meta-analysis of clinical trials: An update
DerSimonian, R., & Kacker, R. (2007) · Contemporary Clinical Trials · doi:10.1016/j.cct.2006.04.004 · Cited by 2,374
Evidence-based health policy—lessons from the Global Burden of Disease Study
Murray, C. J. L., & Lopez, A. D. (1996) · Science · doi:10.1126/science.274.5288.740 · Cited by 2,178
Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A
Lakich, D., Kazazian, H. H., Antonarakis, S. E., & Gitschier, J. (1993) · Nature Genetics · doi:10.1038/ng1193-236 · Cited by 788
Darby, S. C., Kan, S. W., Spooner, R. J., Giangrande, P. L. F., Hill, F. G. H., Hay, C. R. M., Lee, C. A., Ludlam, C. A., & Williams, M. (2007) · Blood · doi:10.1182/blood-2006-10-050435 · Cited by 511
Gringeri, A., Mantovani, L. G., Scalone, L., Mannucci, P. M., & the COCIS Study Group (2003) · Blood · doi:10.1182/blood-2003-03-0941 · Cited by 372
Occurrence of hemophilia in the United States
Soucie, J. M., Evatt, B., Jackson, D., & the Hemophilia Surveillance System Project Investigators (1998) · American Journal of Hematology · doi:10.1002/(sici)1096-8652(199812)59:4<288::aid-ajh4>3.0.co;2-i · Cited by 346
A study of variations in the reported haemophilia A prevalence around the world
STONEBRAKER, J. S., BOLTON‐MAGGS, P. H. B., MICHAEL SOUCIE, J., WALKER, I., & BROOKER, M. (2010) · Haemophilia · doi:10.1111/j.1365-2516.2009.02127.x · Cited by 296
Self-citation450 million years of hemostasis
Davidson, C. J., Tuddenham, E. G., & McVey, J. H. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00334.x · Cited by 169
Mortality and causes of death in Italian persons with haemophilia, 1990–2007
TAGLIAFERRI, A., RIVOLTA, G. F., IORIO, A., OLIOVECCHIO, E., MANCUSO, M. E., MORFINI, M., ROCINO, A., MAZZUCCONI, M. G., FRANCHINI, M., & ON BEHALF OF THE ITALIAN ASSOCIATION OF HEMOPHILIA CENTERS (2010) · Haemophilia · doi:10.1111/j.1365-2516.2009.02188.x · Cited by 168
Self-citation
Cited by
Items 101–200 of 535
Zhang, W., Xie, S., Xue, F., Liu, W., Chen, L., Zhang, L., Wu, J. H., & Yang, R. (2022) · Haemophilia · doi:10.1111/hae.14615 · Cited by 16
Elsheikh, E., Lavin, M., Antunes, L., Larkin, N., Mullaney, B., Doherty, D., Kennedy, M., Keenan, C., Guest, T., O’Mahony, B., et al. (2023) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2023.01.013 · Cited by 16
Kametani, M., Akitomo, T., Usuda, M., Kusaka, S., Asao, Y., Nakano, M., Iwamoto, Y., Tachikake, M., Ogawa, M., Kaneki, A., et al. (2024) · Applied Sciences · doi:10.3390/app14041349 · Cited by 16
Multiplex and multimodal mapping of variant effects in secreted proteins via MultiSTEP
Popp, N. A., Powell, R. L., Wheelock, M. K., Holmes, K. J., Zapp, B. D., Sheldon, K. M., Fletcher, S. N., Wu, X., Fayer, S., Rubin, A. F., et al. (2025) · Nature Structural & Molecular Biology · doi:10.1038/s41594-025-01582-w · Cited by 15
van der Flier, A., Hong, V., Liu, Z., Piepenhagen, P. A., Ulinski, G., Dumont, J. A., Orcutt, K. D., Goel, A., Peters, R., & Salas, J. (2023) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0000000000001230 · Cited by 15
Mobile Health Technology for the Personalized Therapy of Hemophilia
Dîrzu, N., Hotea, I., Jitaru, C., Brînză, M., Urian, L. G., Peters, M.-C., Gal, K., Popescu, L., Blag, C. L., Marian, M., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.711973 · Cited by 15
The musculoskeletal manifestations of haemophilia: a review of the imaging findings
Ray, A. M. P., Colville, J., Hartley, R., & Rowbotham, E. L. (2022) · Clinical Radiology · doi:10.1016/j.crad.2022.06.022 · Cited by 15
Diagnosis of haemophilia and other inherited bleeding disorders ‐ Is a new paradigm needed?
Srivastava, A. (2020) · Haemophilia · doi:10.1111/hae.14042 · Cited by 15
Evolution of congenital haemophilia care in Taiwan
Chen, Y., Chang, C.-Y., Cheng, S., Pan, R., Shih, Y., Li, T., & Wang, S. (2021) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2021.07.017 · Cited by 15
Hemophilia: The Past, the Present, and the Future
Matuk-Villazon, O., Roberts, J. C., & Corrales‐Medina, F. F. (2021) · Pediatrics in Review · doi:10.1542/pir.2020-004143 · Cited by 15
Delgado‐Flores, C. J., García‐Gomero, D., Salvador-Salvador, S., Montes-Alvis, J., Herrera-Cunti, C., & Taype-Rondán, Á. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262273 · Cited by 15
Oliveira, C. C., Charalampous, P., Delaye, J., Grad, D. A., Kolkhir, P., Mechili, E. A., Unim, B., Devleesschauwer, B., & Haagsma, J. A. (2024) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-024-03342-3 · Cited by 14
Kreilgaard, M., Matytsina, I., & Persson, P. (2025) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2025.107162 · Cited by 14
Invisible bleeds: Lived experiences and barriers to care for men with hemophilia
Arya, S., Siad, F. M., Wilton, P., Page, D., Boma‐Fischer, L., Floros, G., Winikoff, R., Teitel, J. M., & Sholzberg, M. (2021) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15570 · Cited by 14
O'Donovan, M. T., Singleton, E., Roche, S., McGowan, M. A., Benson, J., Bergin, C., Bird, R., Byrne, M., Duggan, C., Gilmore, R., et al. (2021) · Haemophilia · doi:10.1111/hae.14426 · Cited by 14
van der Sluijs, M., Huyghe, N., Wood, C. E., & Tawil, S. (2021) · Current Medical Research and Opinion · doi:10.1080/03007995.2021.1991901 · Cited by 14
Ali, M. K. M., Naser, A. Y., AbuAlhommos, A. K., Al-Daghastani, T., Alrawashdeh, H. M., Ali, S. M., Alwafi, H. H., Alqurashi, M., Ahmed, A. H. B., & Albarqi, H. (2022) · Cureus · doi:10.7759/cureus.30179 · Cited by 14
Association of factor expression levels with annual bleeding rate in people with haemophilia B
Burke, T., Shaikh, A., Ali, T. M., Li, N., Konkle, B. A., Noone, D., O’Mahony, B., Pipe, S. W., & O’Hara, J. (2022) · Haemophilia · doi:10.1111/hae.14675 · Cited by 14
Windyga, J., Apte, S., Frei‐Jones, M. J., Fujii, T., Lyu, C. J., Martinez, L. V., Sathar, J., Stasyshyn, O., Tran, H. A., Zozulya, N. I., et al. (2024) · European Journal Of Haematology · doi:10.1111/ejh.14277 · Cited by 13
Clinical perspective: Advancing hemophilia treatment through gene therapy approaches
Thornburg, C. D., PIPE, S. W., Cantore, A., Unzu, C., Jones, M., & Miesbach, W. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.04.023 · Cited by 13
Overview of gene therapy for hemophilia: questions and answers to navigate the innovation
Hoffmann, P., Bitto, N., Mura, V. L., & Miesbach, W. (2025) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2025.12.011 · Cited by 12
Olivieri, M., Simpson, M. L., Yan, S., Fedorovsky, J., Zhang, X., Tomic, R., Pinachyan, K., & Mancuso, M. E. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2062180 · Cited by 12
Gene therapy in haemophilia: literature review and regional perspectives for Turkey
Kavaklı, K., Antmen, B., Okan, V., Şahin, F., Aytaç, S., Balkan, C., Berber, E., Kaya, Z., Küpesiz, A., & Zülfikar, B. (2022) · Therapeutic Advances in Hematology · doi:10.1177/20406207221104591 · Cited by 12
Factor IX inhibitors in haemophilia B: A report of National Haemophilia Registry in China
Dou, X., Zhang, W., Poon, M., Zhang, X., Wu, R., Feng, X., Yang, L., Cheng, P., Chen, S., Wang, Y., et al. (2022) · Haemophilia · doi:10.1111/hae.14665 · Cited by 12
Management of Severe Hemophilia A: Low-Dose Prophylaxis vs. On-Demand Treatment
Ali, R. M., Abid, M., Zafar, S., Ali, M. S., Nadeem, R., Ahmed, R., & Borhany, M. (2023) · Cureus · doi:10.7759/cureus.41410 · Cited by 12
Gene Therapy in Hemophilia: A Transformational Patient Experience
Rasul, E., Hallock, R., Hellmann, M., Konduros, J., Pembroke, L., LeCleir, G., Malacan, J., & Mackensen, S. V. (2023) · Journal of Patient Experience · doi:10.1177/23743735231193573 · Cited by 12
Inhibitors and mortality in persons with nonsevere hemophilia A in the United States
Lim, M. Y., Cheng, D., Recht, M., Kempton, C. L., & Key, N. S. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020002626 · Cited by 12
The German Hemophilia Registry: Growing with Its Tasks
Duda, H., Hesse, J., Haschberger, B., Hilger, A., & Keipert, C. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113408 · Cited by 12
Oral tolerance to prevent anti-drug antibody formation in protein replacement therapies
Rana, J., Muñoz-Melero, M., & Biswas, M. (2022) · Cellular Immunology · doi:10.1016/j.cellimm.2022.104641 · Cited by 12
Mendez, M., Castillo, F., Probyn, L. J., Kras, S., & Tyrrell, P. N. (2024) · International Journal of Computer Assisted Radiology and Surgery · doi:10.1007/s11548-024-03309-6 · Cited by 11
Chowdary, P., Lentz, S. R., Gil, L., López‐Jaime, F. J., Windyga, J., Clausen, W. H. O., Laursen, P. N., & Mahlangu, J. N. (2025) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2025.103207 · Cited by 11
Minno, G. D., Spadarella, G., Maldonato, N. M., Lucia, N. D., Castaman, G., CRISTOFARO, R. D., Santoro, C., Peyvandi, F., Borrelli, A., Lupi, A., et al. (2023) · Blood Reviews · doi:10.1016/j.blre.2023.101118 · Cited by 11
Ekiaby, M. E., Diop, S., Gouider, E., & Moftah, F. (2023) · Vox Sanguinis · doi:10.1111/vox.13555 · Cited by 11
Sun, H., Klaassen, R. J., Anger, D. L., Mendell, A. L., & Olatunde, S. (2024) · Haemophilia · doi:10.1111/hae.15026 · Cited by 11
Zhang, L., Handyside, B., Murphy, R., Sihn, C., Xie, L. Y., Vitelli, C., Harmon, D., Sisó, S., Liu, S., Bullens, S., et al. (2019) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2019.11.007 · Cited by 11
Life expectancy and cause of death in individuals with haemophilia A and B in Norway, 1986‐2018
Skjefstad, K., Solberg, O., Glosli, H., von der Lippe, C., & Feragen, K. B. (2020) · European Journal Of Haematology · doi:10.1111/ejh.13494 · Cited by 11
Dargaud, Y. G., & Janbain, M. (2021) · Journal of Blood Medicine · doi:10.2147/jbm.s260923 · Cited by 11
Cortesi, P. A., Fornari, C., Conti, S., Pollio, B., Boccalandro, E. A., Buzzi, A., Carulli, C., Coppola, A., CRISTOFARO, R. D., Minno, M. N. D. D., et al. (2024) · Haemophilia · doi:10.1111/hae.14943 · Cited by 10
The Dental Management of Patients With Common Hematological Disorders and Bleeding Tendency
Rohani, M. M., & Fisal, A. A. (2025) · Special Care in Dentistry · doi:10.1111/scd.70090 · Cited by 10
Recht, M., He, C., Chen, E., Cheng, D., Solari, P. G., & Hinds, D. R. (2022) · eJHaem · doi:10.1002/jha2.412 · Cited by 10
Bertolini, T. B., Herzog, R. W., Kumar, S. R. P., Sherman, A., Rana, J., Kaczmarek, R., Yamada, K., Arisa, S., Lillicrap, D., Terhorst, C., et al. (2023) · Cellular Immunology · doi:10.1016/j.cellimm.2023.104675 · Cited by 10
An intronic RNA element modulates Factor VIII exon-16 splicing
Tse, V., Chacaltana, G., Gutierrez, M. E., Forino, N. M., Jimenez, A. G., Tao, H., Phong, H., Oh, C., Chary, P., Quesada, I., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad1034 · Cited by 10
Iyar, S., Gebremariam, G. T., Beyene, D. A., Gebremedhin, A., & Tadesse, T. A. (2024) · Journal of Pharmaceutical Health Care and Sciences · doi:10.1186/s40780-023-00326-6 · Cited by 10
Hakimi, Z., Ghelani, R., Bystrická, L., Kragh, N., Marquis, P., Nazir, J., & McGale, N. (2024) · Journal of health economics and outcomes research · doi:10.36469/001c.123374 · Cited by 10
Knight, K. A., Coyle, C. W., Radford, C. E., Parker, E. T., Fedanov, A., Shields, J. M., Szlam, F., Purchel, A. A., Chen, M., Denning, G., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021004742 · Cited by 10
Fonck, C., Su, C., Arens, J., Koziol, E., Srimani, J. K., Henshaw, J., Tuyl, A. V., Chandra, S. A. M., Vettermann, C., & O’neill, C. A. (2022) · Gene Therapy · doi:10.1038/s41434-022-00318-5 · Cited by 10
The Correlation Between the HEAD‐US‐C Score and HJHS in Hemophilic Arthropathy of the Knee
Fang, Y., Guo, Y., Qin, T., Luan, Y., & Zhang, C. (2022) · Journal of Ultrasound in Medicine · doi:10.1002/jum.16072 · Cited by 10
Cardiovascular Risk Factors in Patients with Congenital Hemophilia: A Focus on Hypertension
Bădescu, M. C., Bădulescu, O. V., Butnariu, L. I., Bojan, I. B., Vladeanu, M. C., Dima, N., Vlad, C.-E., Foia, L. G., Ciocoiu, M., & Rezuș, C. (2022) · Diagnostics · doi:10.3390/diagnostics12122937 · Cited by 10
Ketteler, C., Hoffmann, I., Davidson, S. J., Chen, D. J., Tiede, A., & Richter, N. (2022) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12799 · Cited by 10
Grazzi, E. F., Hawes, C. R., Camp, C., Hinds, D. R., O’Hara, J., & Burke, T. (2024) · Health and Quality of Life Outcomes · doi:10.1186/s12955-024-02267-6 · Cited by 10
Demographics, clinical profile and treatment landscape of patients with haemophilia B in China
Zhang, W., Song, X., Dou, X., Poon, M., Liu, W., Chen, L., Zhang, L., Xue, F., & Yang, R. (2022) · Haemophilia · doi:10.1111/hae.14484 · Cited by 10
Treatment of Hemophilia — More Amazing Progress
Mannucci, P. M. (2020) · New England Journal of Medicine · doi:10.1056/nejme2024545 · Cited by 10
Global patterns of hemophilia drug trials, hemophilia care, and health care measures
Fedewa, S. A., Valentino, L. A., Koo, A., Cafuir, L. A., Gillespie, T. W., Buckner, T. W., Tran, D. Q., Antun, A. G., & Kempton, C. L. (2025) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2025.102714 · Cited by 9
Muzambi, R., Bottle, A., Dexter, D., Augustine, C., Joseph, J., Dasaolu, F., Carr, S. B., Reynolds, C., Sathyamoorthy, G., James, J., et al. (2025) · The Lancet Haematology · doi:10.1016/s2352-3026(25)00235-2 · Cited by 9
Racial and ethnic differences in reported haemophilia death rates in the United States
Fedewa, S. A., Payne, A. B., Tran, D. Q., Cafuir, L. A., Antun, A. G., & Kempton, C. L. (2023) · Haemophilia · doi:10.1111/hae.14859 · Cited by 9
Chuansumrit, A., Ruchutrakul, T., Sirachainan, N., Kitpoka, P., Panuwannakorn, M., Panburana, P., Suwannuraks, M., Sri‐Udomporn, N., Kijkunasathian, C., Jaovisidha, S., et al. (2023) · Expert Review of Hematology · doi:10.1080/17474086.2023.2293092 · Cited by 9
Ucero‐Lozano, R., Pérez‐Llanes, R., Cuesta‐Barriuso, R., & Donoso‐Úbeda, E. (2024) · Pharmaceuticals · doi:10.3390/ph17070835 · Cited by 9
Borràs, N., Castillo‐González, D., Comes, N., Martín-Fernández, L., Jimenez, R. A. R., Monteagudo, A. C., Ruiz‐Moleón, V., Garrote‐Santana, H., Vidal, F., & Abraham, C. M. (2021) · Haemophilia · doi:10.1111/hae.14438 · Cited by 9
Serum TNF‐ α Level as a Possible Predictor of Inhibitor Levels in Severe Hemophilia A
Susanah, S., Raspati, H., Sari, N. M., Rakhmilla, L. E., Sribudiani, Y., Moestopo, O., Sinaga, P., Idjradinata, P. S., & Maskoen, A. M. (2021) · BioMed Research International · doi:10.1155/2021/6483490 · Cited by 9
Touré, S. A., Seck, M., Sy, D., Bousso, E. S., Faye, B. F., & Diop, S. (2022) · Hematology · doi:10.1080/16078454.2022.2047286 · Cited by 9
Severe Hemophilia A and Moyamoya Syndrome in a 19-Year-Old Boy Caused by Xq28 Microdeletion
Tzeravini, E., Samara, S., Kouramba, A., Vakrinos, G., Efthimiou, A., Tzetis, M., & Ανδρουτσάκος, Θ. (2022) · Case Reports in Neurology · doi:10.1159/000524482 · Cited by 9
Characteristics of BAY 2599023 in the Current Treatment Landscape of Hemophilia A Gene Therapy
Pipe, S. W., Arruda, V. R., Lange, C., Kitchen, S., Eichler, H., & Wadsworth, S. C. (2022) · Current Gene Therapy · doi:10.2174/1566523222666220914105729 · Cited by 9
Structure of coagulation factor VIII bound to a patient-derived anti-C1 domain antibody inhibitor
Childers, K. C., Avery, N. G., Alamo, K. A. E., Davulcu, O., Haynes, R. M., Lollar, P., Doering, C. B., Coxon, C. H., & Spiegel, P. C. (2023) · Blood · doi:10.1182/blood.2023020181 · Cited by 9
Clearfield, E., Chang, H., Janssen, E. M., Majid, T., Messner, D. A., Coffin, D., Jain, M. M., Monahan, P. E., Valentino, L. A., Witkop, M., et al. (2024) · Haemophilia · doi:10.1111/hae.15085 · Cited by 8
Self-citationvan Stam, L. E., Lacroix‐Desmazes, S., Fijnvandraat, K., & Gouw, S. C. (2025) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2024.12.039 · Cited by 8
Gringeri, A., Mannucci, P. M., Gringeri, M., Castaman, G., & Peyvandi, F. (2025) · Haematologica · doi:10.3324/haematol.2025.287572 · Cited by 8
Pham, Q. D. M., Thomson, S. M., Schaible, B., Mills, K. D., Atala, A., Porada, C. D., & Almeida-Porada, G. D. (2023) · Haemophilia · doi:10.1111/hae.14805 · Cited by 8
Rodriguez, M., Trevisan, B., Ramamurthy, R. M., George, S. K., Diaz, J., Alexander, J., Meares, D., Schwahn, D. J., Quilici, D. R., Figueroa, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39986-1 · Cited by 8
Pérez‐Alenda, S., Carrasco, J. J., Querol, F., Megías‐Vericat, J. E., Querol‐Giner, F., Sánchez-Sánchez, M. L., Bonanad, S., & Núñez‐Cortés, R. (2024) · Haemophilia · doi:10.1111/hae.14988 · Cited by 8
Benemei, S., Mattia, C., & Minno, M. N. D. D. (2024) · Haemophilia · doi:10.1111/hae.15002 · Cited by 8
Hannah, W. B., Drumm, M. L., Nykamp, K., Pramparo, T., Steiner, R. D., & Schrodi, S. J. (2024) · Genetics in Medicine Open · doi:10.1016/j.gimo.2024.101881 · Cited by 8
Advances in biopharmaceutical products for hemophilia
Wu, J., Liu, X., Yang, H., He, Y., & Yu, D. (2024) · iScience · doi:10.1016/j.isci.2024.111436 · Cited by 8
Plasmid Gene Therapy for Monogenic Disorders: Challenges and Perspectives
Luís, M. Â., Goes, M. A. D., Santos, F. M., Mesquita, J., Tavares-Ratado, P., & Tomaz, C. T. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17010104 · Cited by 8
Global Trends in Hemophilia Research
Özlü, C., & Ceylan, G. (2022) · Black Sea Journal of Health Science · doi:10.19127/bshealthscience.1092964 · Cited by 8
Reflections on the Canadian Bleeding Disorders Registry: Lessons Learned and Future Perspectives
Iorio, A., Grenier, S., Page, D., Keepanasseril, A., Iserman, E. C., Tarride, J., Matino, D., Stoffman, J. M., Teitel, J. M., & Boyle, L. (2022) · Canadian Journal of Health Technologies · doi:10.51731/cjht.2022.425 · Cited by 8
Self-citationPipe, S. W., Dunn, A. L., & Young, G. A. (2023) · Expert Review of Hematology · doi:10.1080/17474086.2023.2248385 · Cited by 8
The importance and evolution of bleeding disorder registries
Tran, H. A., Yang, R., Fischer, K., Makris, M., & Konkle, B. A. (2024) · Haemophilia · doi:10.1111/hae.14993 · Cited by 8
Self-citationGlobal Hemophilia Care: Data for Action
Soucie, J. M. (2019) · Annals of Internal Medicine · doi:10.7326/m19-2535 · Cited by 8
Wheeler, A. P., Abraham, A., Barnes, C. D., Frandsen, R. B., d’Oiron, R., Eichler, H., Hampton, K. K., López‐Jaime, F. J., Lyu, C. J., Tavares, C. M. M., et al. (2025) · Haemophilia · doi:10.1111/hae.70051 · Cited by 7
Gene Therapy of Haemophilia: Current Status and Future Directions
Miesbach, W. (2026) · Hämostaseologie · doi:10.1055/a-2751-7625 · Cited by 7
Testing strategies used in the diagnosis of rare inherited bleeding disorders
Pruthi, R. K. (2023) · Expert Review of Hematology · doi:10.1080/17474086.2023.2211257 · Cited by 7
Health utilities in adults with hemophilia A: A retrospective cohort study
Hirniak, S., Edginton, A. N., Iorio, A., Alsabbagh, M. W., Hajducek, D. M., & Wong, W. W. L. (2024) · Haemophilia · doi:10.1111/hae.14979 · Cited by 7
Self-citationAbood, G. M., Dehiol, R. K., & Mones, H. M. (2024) · Global Pediatric Health · doi:10.1177/2333794x241280119 · Cited by 7
Windyga, J., Boban, A., Zupan, I. P., O'Connell, N. M., & Hermans, C. R. J. R. (2022) · Therapeutic Advances in Hematology · doi:10.1177/20406207221088462 · Cited by 7
Comprehensive approach to hemophilia
Gök, V., & Ünal, E. (2022) · Journal of Health Sciences and Medicine · doi:10.32322/jhsm.1108174 · Cited by 7
Theory of change and strategic priorities of the world federation of haemophilia
Laliberté, J., Coffin, D., Haffar, A., Mekhuzla, S., Pierce, G. F., Flynn, B., Márquez, C. S., Hermans, C. R. J. R., Garrido, C., & Baumann, A. (2022) · Haemophilia · doi:10.1111/hae.14673 · Cited by 7
Self-citationNemes, A., Kormányos, Á., Domsik, P., Ambrus, N., Gyenes, N., Vezendi, K., Marton, I., & Borbényi, Z. (2021) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-21-30 · Cited by 7
Ketteler, C., Hoffmann, I., Davidson, S. J., Tiede, A., & Richter, N. (2021) · Haemophilia · doi:10.1111/hae.14416 · Cited by 7
Current Therapies in Hemophilia: From Plasma-Derived Factor Modalities to CRISPR/Cas Alternatives
Lara-Navarro, I. J., & Jaloma‐Cruz, A. R. (2022) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.256.197 · Cited by 7
Yuan, S., Song, L., Jiang, H., Wang, J., Ning, X., & Jiang, W. (2022) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-022-03217-y · Cited by 7
Risk of low bone mineral density in patients with haemophilia: a systematic review and meta-analysis
Zhou, H., Chen, L., Su, H., Chen, G., & Tong, P. (2024) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-023-04499-6 · Cited by 7
Genetics of Hemophilia A and B
Sanchez-Lara, P. A., & Valentino, L. A. (2022) · Springer eBooks · doi:10.1007/978-3-030-93990-8_2 · Cited by 7
Patient anti-FVIII drug antibodies bind preferentially to a subset of FVIII covalent states
Butera, D., Pijning, A. E., Avery, N. G., Coxon, C. H., Metcalfe, C. L., Mimoun, A., Lacroix‐Desmazes, S., Spiegel, P. C., & Hogg, P. J. (2025) · Blood Advances · doi:10.1182/bloodadvances.2025016474 · Cited by 6
Advances in Gene Therapy Clinical Trials for Hemophilia Care
Rana, A. J., Hussain, M. S., Jakhmola, V., & Gupta, G. (2025) · Current Gene Therapy · doi:10.2174/0115665232413510250904105956 · Cited by 6
Therapeutic base editing to generate a gain-of-function F9 variant for hemophilia B
Baatartsogt, N., Kashiwakura, Y., Hiramoto, T., Ito, R., Sato, R., Nagao, Y., Naruoka, H., Takata, H., Hayakawa, M., Batjargal, K., et al. (2025) · Blood · doi:10.1182/blood.2024027870 · Cited by 6
Haemophilia in South Asia: A perspective from Bangladesh
Hossain, M. S., & Mosabbir, A. A. (2021) · Haemophilia · doi:10.1111/hae.14445 · Cited by 6
Analysis of hospitalization of people with hemophilia—12 years of experience in a single center
Qu, C., Liu, W., Chen, L., Zhang, L., Xue, F., & Yang, R. (2022) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12764 · Cited by 6
Meunier, S., Harroche, A., Rauch, A., Bally, C., Huguenin, Y., Voltzenlogel, R., Tabélé, C., Chambost, H., Balençon, M., & FranceCoag (2024) · Haemophilia · doi:10.1111/hae.15033 · Cited by 6
Self-citationManagement of Hemophilia Carriers
Escobar, M. A., Larson, J., & Montanez, N. A. (2022) · Springer eBooks · doi:10.1007/978-3-030-93990-8_9 · Cited by 6
Fraticelli, L., Freyssenge, J., Promé-Combel, E., Agnellet, E., Dargaud, Y. G., & Chamouard, V. (2023) · JMIR Research Protocols · doi:10.2196/43091 · Cited by 6
Metadata
- Authors
- Iorio, A., Stonebraker, J. S., Chambost, H., Makris, M., Coffin, D., Herr, C., Germini, F., & for the Data and Demographics Committee of the World Federation of Hemophilia*
- Affiliations
- McMaster University (CA)
- North Carolina State University (US)
- La Timone Hospital of Assistance Publique – Hôpitaux de Marseille, Aix-Marseille University, Institut National de la Santé et de la Recherche Médicale, and Institut National de la Recherche Agronomique, Marseille, France (H.C.)
- University of Sheffield (GB)
- World Federation of Hemophilia (CA)
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2019-10-15
- Volume
- 171
- Issue
- 8
- Pages
- 540-546
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2972722566
- Cited by
- 462
- References
- 45
- Citations by year
- 2026: 57 · 2025: 76 · 2024: 80 · 2023: 71 · 2022: 75 · 2021: 64 · 2020: 34 · 2019: 4
- FWCI
- 7.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (submittedVersion)
- Annals of Internal Medicine
- Topics
- Health Sciences › Medicine › Hematology › Hemophilia Treatment and Research
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Keywords
- hemophilia, hemophilia A, hemophilia B, prevalence, life expectancy, disease burden, severe hemophilia, years of life lost
- MeSH terms
- Australia, Canada, France, United Kingdom, Hemophilia A, Humans, Infant, Newborn, Italy, Life Expectancy, Male, New Zealand, Registries, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.